
#Antibody #therapeutics lead #biologics with advances in monoclonal and next-gen formats. Strong results in oncology and rare diseases boost use. Innovation and AI speed development, while competition expands access and growth.
Read More@ futuredatastats.com/antibody-thera…

English


















